QUEST Community Science Blog
Plopped down on a sand dune in Death Valley, one gains a certain appreciation for both the national parks and natural "quiet."
Nearly 15 million Americans suffer from depression. Learn why depression is more than just "feeling blue," the difficulties of treating it with traditional medications and how new tools
and research are shedding light on brain structures that may play an integral role in treating it.
What is the link between anxiety and depression, and can a form of talk therapy help treat both conditions? Learn more in an extended interview with Philippe Goldin, Clinical Research Scientist for the Clinically Applied Affective Neuroscience Group at Stanford University.
Through Youth Speaks Green, we’ll explore how young people in the Bay Area view the challenges of becoming green. We’ll be looking beyond clean fuels, efficient vehicles and solar panel rebates and delving instead into the personal.
Imagine a medical disease that afflicts eighteen million people in the U.S., for which more than 160 million prescriptions were filled in 2008, that is one of the leading causes of disability in the U.S., but a disease for which no definitive medical model of pathology exists.
Chess grandmaster Gary Kasparov lost to IBM's Deep Blue in 1997, but while this was a cultural landmark for Artificial Intelligence, Poker is a more meaningful challenge for researchers.
Why do some people get severely sick from swine flu and others barely feel it? As flu season ramps up, scientists at UCSF's Viral Discovery Center are racing to learn more about the 2009 H1N1 virus, including how it's evolving, and whether our current treatments will remain effective.
As the satellite impact grows closer, NASA is making an effort to talk about the locally driven mission. Many of the upcoming talks are suitable for any audience, from kids to adults.
We all know that, thanks to our DNA, each of us is a little bit different. Some of those differences are obvious, like eye and hair color, but others are not so obvious, like how our bodies react to medication. Researchers are beginning to look at how to tailor medical treatments to our genetic profiles. Some of the biggest breakthroughs have been in cancer treatment.
You've probably heard about some of the breakthroughs in personal genome sequencing, where companies take a look at your DNA and send back your risk profile. But there's a flip side to all this genetic research that doesn't have to do with risk: personalized medicine.